Semus Wealth Partners LLC Sells 181 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Semus Wealth Partners LLC decreased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 603 shares of the medical equipment provider’s stock after selling 181 shares during the period. Semus Wealth Partners LLC’s holdings in Intuitive Surgical were worth $315,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. M.E. Allison & CO. Inc. bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after buying an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its holdings in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Barclays lifted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Raymond James upped their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Leerink Partners lifted their target price on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $601.17 on Wednesday. The business’s 50 day simple moving average is $561.88 and its 200 day simple moving average is $522.27. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $214.12 billion, a P/E ratio of 93.79, a P/E/G ratio of 5.74 and a beta of 1.39.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 6,348 shares of company stock worth $3,587,582. 0.80% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.